This research study is designed to look at the effectiveness of bupropion for reducing binge
eating in overweight persons with binge eating problems. Participants in the study will
receive either bupropion or placebo ("sugar" pill, inactive medication) as an outpatient for
eight weeks. In addition, participants will be given the option to receive 8 weeks of free
behavioral weight loss treatment. This treatment, known to be effective for reducing binge
eating and helping people lose weight, will be administered following the medication phase
and at no cost.
It is expected that compared to placebo, bupropion will produce greater reductions in binge
eating.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)